Show simple item record

dc.contributor.authorErnawati, Teni
dc.contributor.authorYuliani, Tri
dc.contributor.authorMinarti, M
dc.contributor.authorDewijanti, Indah Dwiatmi
dc.date.accessioned2020-01-22T01:38:07Z
dc.date.available2020-01-22T01:38:07Z
dc.date.issued2019
dc.identifier.citation1. Aman, K.A. (2005). Oklusi Pembuluh Darah dan Permasalahannya. Jakarta, 12-15. 2. Rosmiati, H., Gan, V.H.S. (1995). Antikoagulan, Antitrombosit, Trombolitik dan Haemostatik dalam Farmakologi dan Terapi. Edisi ke-4. Jakarta: Gaya Baru,755-762. 3. McAdam, B.F., Catella-Lawson, F., Mardini, I.A., Kapoor, S., Lawson, J.A., FitzGerald, G.A. (1999). Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA. 96, 272–277. 4. Bensen, W.G., Fiechther, J.J., McMirren, J.I., (1999). Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial. Mayo Clin Proc 74, 1095-1105. 5. Ehrich, E.W. (1999). Effect of specific Cox-2 inhibition in osteoarthritis of the knee: a 6 week double blind placebo controlled pilot study of rofecoxib. J Rheumatol 26,2438-2447. 6. Cannon, G.W., Caldwell, J.R., Holt, P. (2000). Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol O35 Study Group. Arthritis Rheum 43,978-987. 7. Motiejunas, D., Wade, R.C. (2006). Computer-Assisted Drug Design, Structural, Energetics, and Dynamic Aspects of Ligand-Receptor Interactions. 8. Taylor, J.B., Triggle, D.J. (2006) Comprehensive Medicinal Chemistry II Volume 4, Elsevier. 9. Yuniarti, N., Ikawati, Z., Istyastono, E.P. (2011). The importance of ARG513 as a hydrogen bond anchor to discover COX-2 inhibitors in a virtual screening campaign. Bioinformation, 6, 164-166. 10. Ernawati, T. 2012. Penapisan Virtual senyawa turunan Metil sinamat pada enzim siklooksigenase-2(COX-2). Jurnal Kimia Terapan Indonesia, 14, 63-70. 11. O’Boyle, N.M., Banck, M., James, C., Morley, C., Vandermeersch, T., Hutchison, G.R. (2011). Open Babel. An open chemical toolbox. Journal of Cheminformatics, 3, 33-36. 12. Ten Brink, T., Exner, T.E. (2009). Influence of protonation, tautomeric, and stereoisomeric states on protein-ligand docking results. J. Chem. Inf. Model, 49, 1535-1546. 13. Korb, O., Stützle, T., Exner, T.E. (2009). Empirical scoring functions for advanced proteinligand docking with PLANTS. J. Chem. Inf. Model, 49, 84-96. 14. Penning, T.D., Talley, J.J., Bertenshaw, S.R. Carter, J.S., Collins, P.W., Docter, S., Graneto, M.J., Lee, L. F., Malecha, J.W., Miyashiro, J.M., Rogers, R.S., Rogier, D.J., Yu, S.S., Anderson, G.D, Burton, E.G., Cogburn, J.N., Gregory, S., Koboldt, C.M., Perkins, W.E., Seibert, K., Veenhuizen, W., Zhang, Y.Y., Isakson, P. C. (1997). Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene sulfonamide (SC- 58635, celecoxib). J. Med. Chem., 40, 1347-1365. 15. Kurumbail, R., Stevens, A., Gierse, J. (1996). Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature, 384, 644-648.id_ID
dc.identifier.issn2615-1588
dc.identifier.urihttp://hdl.handle.net/11617/11817
dc.description.abstractPurpose: The purpose of this study was to evaluate the anti-inflammatory activity of cinnamic acid and 3-phenyl propanoic acid and also virtual screening of the methyl trans-cinnamate derivatives were carried out on the COX-2 enzyme. Methodology: The cinnamic acid and 3-phenylpropanoic acid were tested for anti-inflamatory activity in vivo using carageenan-induced rat paws edema method. Thirty male Sprague-Dawley rats were divided into 5 groups: control group, Na diclofenac (0.45 mg/kg body weight), ibuprofen (7.2 mg/kg body weight ), cinnamic acid (14.4 mg/kg body weight) and 3-phenyl propionate acid (14.4 mg/kg body weight). Paw edema was observed using a plethysmometer for 46 hours, these were at 0, 0.5, 2, 3, 4, 5, 22, 29 and 46 hours. Each compound of methyl trans-cinnamate derivatives to be performed molecular docking, virtual constructed in the form of two-dimensional (2D) using BKChem application. The simulation molecular docking using PLANTS 1.1. The structure of methyl trans-cinnamate derivatives was characterized by IR, melting point, UV, 1H NMR, 13C NMR, and mass spectral analysis. Results: The result showed that antiinflamatory activity of Na diclofenac, ibuprofen, cinnamic acid, and 3-phenil propionic acid were -20,6 %, -3,7 %, -43,2 %, 27,7 % respectively. These results showed only 3-phenil propionic acid could reduce edema in the rats’ paw. The docking results show that cinnamic acid, 3-phenyl propanoic acid and 3- (4-benzoylphenyl) propanoic acid are predict to have activity as COX-2 inhibitors.id_ID
dc.language.isootherid_ID
dc.publisherISETH 2019 (International Summit on Science, Technology, and Humanity)id_ID
dc.titleAnti-inflammatory Activities of Methyl trans-Cinnamate derivatives on Carrageenan-Induced Paw Edema in Male Sprague-Dawley Ratsid_ID
dc.typeArticleid_ID


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record